These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18546342)

  • 1. Cerebellar ataxia as a possible organ-specific autoimmune disease.
    Hadjivassiliou M; Boscolo S; Tongiorgi E; Grünewald RA; Sharrack B; Sanders DS; Woodroofe N; Davies-Jones GA
    Mov Disord; 2008 Jul; 23(10):1370-7. PubMed ID: 18546342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebellar ataxia, peripheral neuropathy, "gluten sensitivity" and anti-neuronal autoantibodies.
    Lock RJ; Tengah DP; Williams AJ; Ward JJ; Bingley PJ; Wills AJ; Unsworth DJ
    Clin Lab; 2006; 52(11-12):589-92. PubMed ID: 17175889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gluten sensitivity in sporadic and hereditary cerebellar ataxia.
    Bushara KO; Goebel SU; Shill H; Goldfarb LG; Hallett M
    Ann Neurol; 2001 Apr; 49(4):540-3. PubMed ID: 11310636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
    Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
    Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics.
    Hadjivassiliou M; Grünewald R; Sharrack B; Sanders D; Lobo A; Williamson C; Woodroofe N; Wood N; Davies-Jones A
    Brain; 2003 Mar; 126(Pt 3):685-91. PubMed ID: 12566288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebellar ataxia after malaria.
    Teo JT; Swayne OB; Silber E
    Neurology; 2009 Jul; 73(1):73-4. PubMed ID: 19564588
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibodies to myelin protein zero (P0) protein as markers of auto-immune inner ear diseases.
    Pham BN; Rudic M; Bouccara D; Sterkers O; Belmatoug N; Bébéar JP; Couloigner V; Fraysse B; Gentine A; Ionescu E; Robier A; Sauvage JP; Truy E; Van Den Abbeele T; Ferrary E
    Autoimmunity; 2007 May; 40(3):202-7. PubMed ID: 17453719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological reactivity against neuronal and non-neuronal antigens in sporadic adult-onset cerebellar ataxia.
    Fancellu R; Pareyson D; Corsini E; Salsano E; Laurà M; Bernardi G; Antozzi C; Andreetta F; Colecchia M; Di Donato S; Mariotti C
    Eur Neurol; 2009; 62(6):356-61. PubMed ID: 19786780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical presentation of immune mediated cerebellar ataxia].
    Honnorat J; Trouillas P
    Rev Neurol (Paris); 2003 Jan; 159(1):11-22. PubMed ID: 12618649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.
    Jones AL; Flanagan EP; Pittock SJ; Mandrekar JN; Eggers SD; Ahlskog JE; McKeon A
    JAMA Neurol; 2015 Nov; 72(11):1304-12. PubMed ID: 26414229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
    Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
    Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and magnetic resonance imaging characteristics of sporadic cerebellar ataxia.
    Bürk K; Bühring U; Schulz JB; Zühlke C; Hellenbroich Y; Dichgans J
    Arch Neurol; 2005 Jun; 62(6):981-5. PubMed ID: 15956170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 16q-linked autosomal dominant cerebellar ataxia: a clinical and genetic study.
    Ouyang Y; Sakoe K; Shimazaki H; Namekawa M; Ogawa T; Ando Y; Kawakami T; Kaneko J; Hasegawa Y; Yoshizawa K; Amino T; Ishikawa K; Mizusawa H; Nakano I; Takiyama Y
    J Neurol Sci; 2006 Sep; 247(2):180-6. PubMed ID: 16780885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibody-mediated disorders of the central nervous system.
    Irani S; Lang B
    Autoimmunity; 2008 Feb; 41(1):55-65. PubMed ID: 18176865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmunity as a prognostic factor in sporadic adult onset cerebellar ataxia.
    Sivera R; Martín N; Boscá I; Sevilla T; Muelas N; Azorín I; Vílchez JJ; Bolonio M; Donat E; Ribes-Koninckx C; Bataller L
    J Neurol; 2012 May; 259(5):851-4. PubMed ID: 21984193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to cerebellar nerve fibres in two patients with paraneoplastic cerebellar ataxia.
    Balegno S; Ceroni M; Corato M; Franciotta D; Giometto B; Marinu-Aktipu K; Nano R
    Anticancer Res; 2005; 25(5):3211-4. PubMed ID: 16101129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and genetic epidemiological study of 16q22.1-linked autosomal dominant cerebellar ataxia in western Japan.
    Hayashi M; Adachi Y; Mori M; Nakano T; Nakashima K
    Acta Neurol Scand; 2007 Aug; 116(2):123-7. PubMed ID: 17661799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent acute cerebellar ataxia associated with anti-cardiolipin antibodies.
    Ishikawa N; Kobayashi M
    Brain Dev; 2010 Aug; 32(7):588-91. PubMed ID: 19703737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of fractional anisotropy changes in white matter of cerebellar peduncles distinguish spinocerebellar ataxia-1 from multiple system atrophy and other ataxia syndromes.
    Prakash N; Hageman N; Hua X; Toga AW; Perlman SL; Salamon N
    Neuroimage; 2009 Aug; 47 Suppl 2():T72-81. PubMed ID: 19446636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid and celiac diseases autoantibodies in patients with adult chronic idiopathic thrombocytopenic purpura.
    Altintas A; Pasa S; Cil T; Bayan K; Gokalp D; Ayyildiz O
    Platelets; 2008 Jun; 19(4):252-7. PubMed ID: 18569860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.